MaaT Pharma and Accinov sign a partnership agreement for the manufacture of investigational medicinal products. MaaT Pharma and Accinov have announced the signing of a partnership agreement for the creation of a GMP platform for the production of clinical batches for an investigational new drug to cure dysbiosis (imbalance of exchanges between the intestinal microbiome and the host) through  autologous micro-biotherapy, a solution which is currently totally unique; . Read more